The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Pharmaceutical CMO Services Market Research Report 2025

Global Pharmaceutical CMO Services Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1928470

No of Pages : 102

Ask Your Query

Synopsis

Contract Pharmaceutical Manufacturing refers to accept commissioned from pharmaceutical companies, provide the service about API production, agent production, packaging and son on which required for pharmaceutical manufacturing.

The global Pharmaceutical CMO Services market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

In terms of regions, North America is expected to remain the largest market during the forecast period.

This report aims to provide a comprehensive presentation of the global market for Pharmaceutical CMO Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmaceutical CMO Services.

Report Scope

The Pharmaceutical CMO Services market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pharmaceutical CMO Services market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Pharmaceutical CMO Services companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company(Partial List)

  • Catalent
  • Thermo Fisher Scientific
  • Lonza
  • Boehringer Ingelheim
  • Fareva
  • Recipharm
  • Aenova
  • AbbVie
  • Baxter
  • Nipro Corp
  • Sopharma
  • Famar
  • Vetter
  • Shandong Xinhua
  • Piramal
  • Mylan
  • Dr. Reddy’s
  • Zhejiang Hisun
  • Zhejiang Huahai
  • Jubilant

Segment by Type

  • Active Pharmaceutical Ingredients (APIs)
  • Finished Dose Formulations (FDFs)

Segment by Application

  • Pharmaceutical Industry
  • Biotechnology Industry

By Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pharmaceutical CMO Services companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pharmaceutical CMO Services Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Active Pharmaceutical Ingredients (APIs)
1.2.3 Finished Dose Formulations (FDFs)
1.3 Market by Application
1.3.1 Global Pharmaceutical CMO Services Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Pharmaceutical Industry
1.3.3 Biotechnology Industry
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pharmaceutical CMO Services Market Perspective (2019-2030)
2.2 Pharmaceutical CMO Services Growth Trends by Region
2.2.1 Global Pharmaceutical CMO Services Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Pharmaceutical CMO Services Historic Market Size by Region (2019-2024)
2.2.3 Pharmaceutical CMO Services Forecasted Market Size by Region (2025-2030)
2.3 Pharmaceutical CMO Services Market Dynamics
2.3.1 Pharmaceutical CMO Services Industry Trends
2.3.2 Pharmaceutical CMO Services Market Drivers
2.3.3 Pharmaceutical CMO Services Market Challenges
2.3.4 Pharmaceutical CMO Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pharmaceutical CMO Services Players by Revenue
3.1.1 Global Top Pharmaceutical CMO Services Players by Revenue (2019-2024)
3.1.2 Global Pharmaceutical CMO Services Revenue Market Share by Players (2019-2024)
3.2 Global Pharmaceutical CMO Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Pharmaceutical CMO Services Revenue
3.4 Global Pharmaceutical CMO Services Market Concentration Ratio
3.4.1 Global Pharmaceutical CMO Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pharmaceutical CMO Services Revenue in 2023
3.5 Pharmaceutical CMO Services Key Players Head office and Area Served
3.6 Key Players Pharmaceutical CMO Services Product Solution and Service
3.7 Date of Enter into Pharmaceutical CMO Services Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Pharmaceutical CMO Services Breakdown Data by Type
4.1 Global Pharmaceutical CMO Services Historic Market Size by Type (2019-2024)
4.2 Global Pharmaceutical CMO Services Forecasted Market Size by Type (2025-2030)
5 Pharmaceutical CMO Services Breakdown Data by Application
5.1 Global Pharmaceutical CMO Services Historic Market Size by Application (2019-2024)
5.2 Global Pharmaceutical CMO Services Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Pharmaceutical CMO Services Market Size (2019-2030)
6.2 North America Pharmaceutical CMO Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Pharmaceutical CMO Services Market Size by Country (2019-2024)
6.4 North America Pharmaceutical CMO Services Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pharmaceutical CMO Services Market Size (2019-2030)
7.2 Europe Pharmaceutical CMO Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Pharmaceutical CMO Services Market Size by Country (2019-2024)
7.4 Europe Pharmaceutical CMO Services Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pharmaceutical CMO Services Market Size (2019-2030)
8.2 Asia-Pacific Pharmaceutical CMO Services Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Pharmaceutical CMO Services Market Size by Region (2019-2024)
8.4 Asia-Pacific Pharmaceutical CMO Services Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Pharmaceutical CMO Services Market Size (2019-2030)
9.2 Latin America Pharmaceutical CMO Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Pharmaceutical CMO Services Market Size by Country (2019-2024)
9.4 Latin America Pharmaceutical CMO Services Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pharmaceutical CMO Services Market Size (2019-2030)
10.2 Middle East & Africa Pharmaceutical CMO Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Pharmaceutical CMO Services Market Size by Country (2019-2024)
10.4 Middle East & Africa Pharmaceutical CMO Services Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Catalent
11.1.1 Catalent Company Detail
11.1.2 Catalent Business Overview
11.1.3 Catalent Pharmaceutical CMO Services Introduction
11.1.4 Catalent Revenue in Pharmaceutical CMO Services Business (2019-2024)
11.1.5 Catalent Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Detail
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific Pharmaceutical CMO Services Introduction
11.2.4 Thermo Fisher Scientific Revenue in Pharmaceutical CMO Services Business (2019-2024)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 Lonza
11.3.1 Lonza Company Detail
11.3.2 Lonza Business Overview
11.3.3 Lonza Pharmaceutical CMO Services Introduction
11.3.4 Lonza Revenue in Pharmaceutical CMO Services Business (2019-2024)
11.3.5 Lonza Recent Development
11.4 Boehringer Ingelheim
11.4.1 Boehringer Ingelheim Company Detail
11.4.2 Boehringer Ingelheim Business Overview
11.4.3 Boehringer Ingelheim Pharmaceutical CMO Services Introduction
11.4.4 Boehringer Ingelheim Revenue in Pharmaceutical CMO Services Business (2019-2024)
11.4.5 Boehringer Ingelheim Recent Development
11.5 Fareva
11.5.1 Fareva Company Detail
11.5.2 Fareva Business Overview
11.5.3 Fareva Pharmaceutical CMO Services Introduction
11.5.4 Fareva Revenue in Pharmaceutical CMO Services Business (2019-2024)
11.5.5 Fareva Recent Development
11.6 Recipharm
11.6.1 Recipharm Company Detail
11.6.2 Recipharm Business Overview
11.6.3 Recipharm Pharmaceutical CMO Services Introduction
11.6.4 Recipharm Revenue in Pharmaceutical CMO Services Business (2019-2024)
11.6.5 Recipharm Recent Development
11.7 Aenova
11.7.1 Aenova Company Detail
11.7.2 Aenova Business Overview
11.7.3 Aenova Pharmaceutical CMO Services Introduction
11.7.4 Aenova Revenue in Pharmaceutical CMO Services Business (2019-2024)
11.7.5 Aenova Recent Development
11.8 AbbVie
11.8.1 AbbVie Company Detail
11.8.2 AbbVie Business Overview
11.8.3 AbbVie Pharmaceutical CMO Services Introduction
11.8.4 AbbVie Revenue in Pharmaceutical CMO Services Business (2019-2024)
11.8.5 AbbVie Recent Development
11.9 Baxter
11.9.1 Baxter Company Detail
11.9.2 Baxter Business Overview
11.9.3 Baxter Pharmaceutical CMO Services Introduction
11.9.4 Baxter Revenue in Pharmaceutical CMO Services Business (2019-2024)
11.9.5 Baxter Recent Development
11.10 Nipro Corp
11.10.1 Nipro Corp Company Detail
11.10.2 Nipro Corp Business Overview
11.10.3 Nipro Corp Pharmaceutical CMO Services Introduction
11.10.4 Nipro Corp Revenue in Pharmaceutical CMO Services Business (2019-2024)
11.10.5 Nipro Corp Recent Development
11.11 Sopharma
11.11.1 Sopharma Company Detail
11.11.2 Sopharma Business Overview
11.11.3 Sopharma Pharmaceutical CMO Services Introduction
11.11.4 Sopharma Revenue in Pharmaceutical CMO Services Business (2019-2024)
11.11.5 Sopharma Recent Development
11.12 Famar
11.12.1 Famar Company Detail
11.12.2 Famar Business Overview
11.12.3 Famar Pharmaceutical CMO Services Introduction
11.12.4 Famar Revenue in Pharmaceutical CMO Services Business (2019-2024)
11.12.5 Famar Recent Development
11.13 Vetter
11.13.1 Vetter Company Detail
11.13.2 Vetter Business Overview
11.13.3 Vetter Pharmaceutical CMO Services Introduction
11.13.4 Vetter Revenue in Pharmaceutical CMO Services Business (2019-2024)
11.13.5 Vetter Recent Development
11.14 Shandong Xinhua
11.14.1 Shandong Xinhua Company Detail
11.14.2 Shandong Xinhua Business Overview
11.14.3 Shandong Xinhua Pharmaceutical CMO Services Introduction
11.14.4 Shandong Xinhua Revenue in Pharmaceutical CMO Services Business (2019-2024)
11.14.5 Shandong Xinhua Recent Development
11.15 Piramal
11.15.1 Piramal Company Detail
11.15.2 Piramal Business Overview
11.15.3 Piramal Pharmaceutical CMO Services Introduction
11.15.4 Piramal Revenue in Pharmaceutical CMO Services Business (2019-2024)
11.15.5 Piramal Recent Development
11.16 Mylan
11.16.1 Mylan Company Detail
11.16.2 Mylan Business Overview
11.16.3 Mylan Pharmaceutical CMO Services Introduction
11.16.4 Mylan Revenue in Pharmaceutical CMO Services Business (2019-2024)
11.16.5 Mylan Recent Development
11.17 Dr. Reddy’s
11.17.1 Dr. Reddy’s Company Detail
11.17.2 Dr. Reddy’s Business Overview
11.17.3 Dr. Reddy’s Pharmaceutical CMO Services Introduction
11.17.4 Dr. Reddy’s Revenue in Pharmaceutical CMO Services Business (2019-2024)
11.17.5 Dr. Reddy’s Recent Development
11.18 Zhejiang Hisun
11.18.1 Zhejiang Hisun Company Detail
11.18.2 Zhejiang Hisun Business Overview
11.18.3 Zhejiang Hisun Pharmaceutical CMO Services Introduction
11.18.4 Zhejiang Hisun Revenue in Pharmaceutical CMO Services Business (2019-2024)
11.18.5 Zhejiang Hisun Recent Development
11.19 Zhejiang Huahai
11.19.1 Zhejiang Huahai Company Detail
11.19.2 Zhejiang Huahai Business Overview
11.19.3 Zhejiang Huahai Pharmaceutical CMO Services Introduction
11.19.4 Zhejiang Huahai Revenue in Pharmaceutical CMO Services Business (2019-2024)
11.19.5 Zhejiang Huahai Recent Development
11.20 Jubilant
11.20.1 Jubilant Company Detail
11.20.2 Jubilant Business Overview
11.20.3 Jubilant Pharmaceutical CMO Services Introduction
11.20.4 Jubilant Revenue in Pharmaceutical CMO Services Business (2019-2024)
11.20.5 Jubilant Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables

List of Tables
Table 1. Global Pharmaceutical CMO Services Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Active Pharmaceutical Ingredients (APIs)
Table 3. Key Players of Finished Dose Formulations (FDFs)
Table 4. Global Pharmaceutical CMO Services Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Pharmaceutical CMO Services Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Pharmaceutical CMO Services Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Pharmaceutical CMO Services Market Share by Region (2019-2024)
Table 8. Global Pharmaceutical CMO Services Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Pharmaceutical CMO Services Market Share by Region (2025-2030)
Table 10. Pharmaceutical CMO Services Market Trends
Table 11. Pharmaceutical CMO Services Market Drivers
Table 12. Pharmaceutical CMO Services Market Challenges
Table 13. Pharmaceutical CMO Services Market Restraints
Table 14. Global Pharmaceutical CMO Services Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Pharmaceutical CMO Services Market Share by Players (2019-2024)
Table 16. Global Top Pharmaceutical CMO Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical CMO Services as of 2023)
Table 17. Ranking of Global Top Pharmaceutical CMO Services Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Pharmaceutical CMO Services Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Pharmaceutical CMO Services Product Solution and Service
Table 21. Date of Enter into Pharmaceutical CMO Services Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Pharmaceutical CMO Services Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Pharmaceutical CMO Services Revenue Market Share by Type (2019-2024)
Table 25. Global Pharmaceutical CMO Services Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Pharmaceutical CMO Services Revenue Market Share by Type (2025-2030)
Table 27. Global Pharmaceutical CMO Services Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Pharmaceutical CMO Services Revenue Market Share by Application (2019-2024)
Table 29. Global Pharmaceutical CMO Services Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Pharmaceutical CMO Services Revenue Market Share by Application (2025-2030)
Table 31. North America Pharmaceutical CMO Services Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Pharmaceutical CMO Services Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Pharmaceutical CMO Services Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Pharmaceutical CMO Services Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Pharmaceutical CMO Services Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Pharmaceutical CMO Services Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Pharmaceutical CMO Services Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Pharmaceutical CMO Services Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Pharmaceutical CMO Services Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Pharmaceutical CMO Services Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Pharmaceutical CMO Services Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Pharmaceutical CMO Services Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Pharmaceutical CMO Services Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Pharmaceutical CMO Services Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Pharmaceutical CMO Services Market Size by Country (2025-2030) & (US$ Million)
Table 46. Catalent Company Detail
Table 47. Catalent Business Overview
Table 48. Catalent Pharmaceutical CMO Services Product
Table 49. Catalent Revenue in Pharmaceutical CMO Services Business (2019-2024) & (US$ Million)
Table 50. Catalent Recent Development
Table 51. Thermo Fisher Scientific Company Detail
Table 52. Thermo Fisher Scientific Business Overview
Table 53. Thermo Fisher Scientific Pharmaceutical CMO Services Product
Table 54. Thermo Fisher Scientific Revenue in Pharmaceutical CMO Services Business (2019-2024) & (US$ Million)
Table 55. Thermo Fisher Scientific Recent Development
Table 56. Lonza Company Detail
Table 57. Lonza Business Overview
Table 58. Lonza Pharmaceutical CMO Services Product
Table 59. Lonza Revenue in Pharmaceutical CMO Services Business (2019-2024) & (US$ Million)
Table 60. Lonza Recent Development
Table 61. Boehringer Ingelheim Company Detail
Table 62. Boehringer Ingelheim Business Overview
Table 63. Boehringer Ingelheim Pharmaceutical CMO Services Product
Table 64. Boehringer Ingelheim Revenue in Pharmaceutical CMO Services Business (2019-2024) & (US$ Million)
Table 65. Boehringer Ingelheim Recent Development
Table 66. Fareva Company Detail
Table 67. Fareva Business Overview
Table 68. Fareva Pharmaceutical CMO Services Product
Table 69. Fareva Revenue in Pharmaceutical CMO Services Business (2019-2024) & (US$ Million)
Table 70. Fareva Recent Development
Table 71. Recipharm Company Detail
Table 72. Recipharm Business Overview
Table 73. Recipharm Pharmaceutical CMO Services Product
Table 74. Recipharm Revenue in Pharmaceutical CMO Services Business (2019-2024) & (US$ Million)
Table 75. Recipharm Recent Development
Table 76. Aenova Company Detail
Table 77. Aenova Business Overview
Table 78. Aenova Pharmaceutical CMO Services Product
Table 79. Aenova Revenue in Pharmaceutical CMO Services Business (2019-2024) & (US$ Million)
Table 80. Aenova Recent Development
Table 81. AbbVie Company Detail
Table 82. AbbVie Business Overview
Table 83. AbbVie Pharmaceutical CMO Services Product
Table 84. AbbVie Revenue in Pharmaceutical CMO Services Business (2019-2024) & (US$ Million)
Table 85. AbbVie Recent Development
Table 86. Baxter Company Detail
Table 87. Baxter Business Overview
Table 88. Baxter Pharmaceutical CMO Services Product
Table 89. Baxter Revenue in Pharmaceutical CMO Services Business (2019-2024) & (US$ Million)
Table 90. Baxter Recent Development
Table 91. Nipro Corp Company Detail
Table 92. Nipro Corp Business Overview
Table 93. Nipro Corp Pharmaceutical CMO Services Product
Table 94. Nipro Corp Revenue in Pharmaceutical CMO Services Business (2019-2024) & (US$ Million)
Table 95. Nipro Corp Recent Development
Table 96. Sopharma Company Detail
Table 97. Sopharma Business Overview
Table 98. Sopharma Pharmaceutical CMO Services Product
Table 99. Sopharma Revenue in Pharmaceutical CMO Services Business (2019-2024) & (US$ Million)
Table 100. Sopharma Recent Development
Table 101. Famar Company Detail
Table 102. Famar Business Overview
Table 103. Famar Pharmaceutical CMO Services Product
Table 104. Famar Revenue in Pharmaceutical CMO Services Business (2019-2024) & (US$ Million)
Table 105. Famar Recent Development
Table 106. Vetter Company Detail
Table 107. Vetter Business Overview
Table 108. Vetter Pharmaceutical CMO Services Product
Table 109. Vetter Revenue in Pharmaceutical CMO Services Business (2019-2024) & (US$ Million)
Table 110. Vetter Recent Development
Table 111. Shandong Xinhua Company Detail
Table 112. Shandong Xinhua Business Overview
Table 113. Shandong Xinhua Pharmaceutical CMO Services Product
Table 114. Shandong Xinhua Revenue in Pharmaceutical CMO Services Business (2019-2024) & (US$ Million)
Table 115. Shandong Xinhua Recent Development
Table 116. Piramal Company Detail
Table 117. Piramal Business Overview
Table 118. Piramal Pharmaceutical CMO Services Product
Table 119. Piramal Revenue in Pharmaceutical CMO Services Business (2019-2024) & (US$ Million)
Table 120. Piramal Recent Development
Table 121. Mylan Company Detail
Table 122. Mylan Business Overview
Table 123. Mylan Pharmaceutical CMO Services Product
Table 124. Mylan Revenue in Pharmaceutical CMO Services Business (2019-2024) & (US$ Million)
Table 125. Mylan Recent Development
Table 126. Dr. Reddy’s Company Detail
Table 127. Dr. Reddy’s Business Overview
Table 128. Dr. Reddy’s Pharmaceutical CMO Services Product
Table 129. Dr. Reddy’s Revenue in Pharmaceutical CMO Services Business (2019-2024) & (US$ Million)
Table 130. Dr. Reddy’s Recent Development
Table 131. Zhejiang Hisun Company Detail
Table 132. Zhejiang Hisun Business Overview
Table 133. Zhejiang Hisun Pharmaceutical CMO Services Product
Table 134. Zhejiang Hisun Revenue in Pharmaceutical CMO Services Business (2019-2024) & (US$ Million)
Table 135. Zhejiang Hisun Recent Development
Table 136. Zhejiang Huahai Company Detail
Table 137. Zhejiang Huahai Business Overview
Table 138. Zhejiang Huahai Pharmaceutical CMO Services Product
Table 139. Zhejiang Huahai Revenue in Pharmaceutical CMO Services Business (2019-2024) & (US$ Million)
Table 140. Zhejiang Huahai Recent Development
Table 141. Jubilant Company Detail
Table 142. Jubilant Business Overview
Table 143. Jubilant Pharmaceutical CMO Services Product
Table 144. Jubilant Revenue in Pharmaceutical CMO Services Business (2019-2024) & (US$ Million)
Table 145. Jubilant Recent Development
Table 146. Research Programs/Design for This Report
Table 147. Key Data Information from Secondary Sources
Table 148. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pharmaceutical CMO Services Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Pharmaceutical CMO Services Market Share by Type: 2023 VS 2030
Figure 3. Active Pharmaceutical Ingredients (APIs) Features
Figure 4. Finished Dose Formulations (FDFs) Features
Figure 5. Global Pharmaceutical CMO Services Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Pharmaceutical CMO Services Market Share by Application: 2023 VS 2030
Figure 7. Pharmaceutical Industry Case Studies
Figure 8. Biotechnology Industry Case Studies
Figure 9. Pharmaceutical CMO Services Report Years Considered
Figure 10. Global Pharmaceutical CMO Services Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 11. Global Pharmaceutical CMO Services Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Pharmaceutical CMO Services Market Share by Region: 2023 VS 2030
Figure 13. Global Pharmaceutical CMO Services Market Share by Players in 2023
Figure 14. Global Top Pharmaceutical CMO Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical CMO Services as of 2023)
Figure 15. The Top 10 and 5 Players Market Share by Pharmaceutical CMO Services Revenue in 2023
Figure 16. North America Pharmaceutical CMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 17. North America Pharmaceutical CMO Services Market Share by Country (2019-2030)
Figure 18. United States Pharmaceutical CMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. Canada Pharmaceutical CMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Europe Pharmaceutical CMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Pharmaceutical CMO Services Market Share by Country (2019-2030)
Figure 22. Germany Pharmaceutical CMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. France Pharmaceutical CMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. U.K. Pharmaceutical CMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Italy Pharmaceutical CMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Russia Pharmaceutical CMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Nordic Countries Pharmaceutical CMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Asia-Pacific Pharmaceutical CMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Pharmaceutical CMO Services Market Share by Region (2019-2030)
Figure 30. China Pharmaceutical CMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Japan Pharmaceutical CMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. South Korea Pharmaceutical CMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Southeast Asia Pharmaceutical CMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. India Pharmaceutical CMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Australia Pharmaceutical CMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Latin America Pharmaceutical CMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Pharmaceutical CMO Services Market Share by Country (2019-2030)
Figure 38. Mexico Pharmaceutical CMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Brazil Pharmaceutical CMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Middle East & Africa Pharmaceutical CMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Pharmaceutical CMO Services Market Share by Country (2019-2030)
Figure 42. Turkey Pharmaceutical CMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Saudi Arabia Pharmaceutical CMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Catalent Revenue Growth Rate in Pharmaceutical CMO Services Business (2019-2024)
Figure 45. Thermo Fisher Scientific Revenue Growth Rate in Pharmaceutical CMO Services Business (2019-2024)
Figure 46. Lonza Revenue Growth Rate in Pharmaceutical CMO Services Business (2019-2024)
Figure 47. Boehringer Ingelheim Revenue Growth Rate in Pharmaceutical CMO Services Business (2019-2024)
Figure 48. Fareva Revenue Growth Rate in Pharmaceutical CMO Services Business (2019-2024)
Figure 49. Recipharm Revenue Growth Rate in Pharmaceutical CMO Services Business (2019-2024)
Figure 50. Aenova Revenue Growth Rate in Pharmaceutical CMO Services Business (2019-2024)
Figure 51. AbbVie Revenue Growth Rate in Pharmaceutical CMO Services Business (2019-2024)
Figure 52. Baxter Revenue Growth Rate in Pharmaceutical CMO Services Business (2019-2024)
Figure 53. Nipro Corp Revenue Growth Rate in Pharmaceutical CMO Services Business (2019-2024)
Figure 54. Sopharma Revenue Growth Rate in Pharmaceutical CMO Services Business (2019-2024)
Figure 55. Famar Revenue Growth Rate in Pharmaceutical CMO Services Business (2019-2024)
Figure 56. Vetter Revenue Growth Rate in Pharmaceutical CMO Services Business (2019-2024)
Figure 57. Shandong Xinhua Revenue Growth Rate in Pharmaceutical CMO Services Business (2019-2024)
Figure 58. Piramal Revenue Growth Rate in Pharmaceutical CMO Services Business (2019-2024)
Figure 59. Mylan Revenue Growth Rate in Pharmaceutical CMO Services Business (2019-2024)
Figure 60. Dr. Reddy’s Revenue Growth Rate in Pharmaceutical CMO Services Business (2019-2024)
Figure 61. Zhejiang Hisun Revenue Growth Rate in Pharmaceutical CMO Services Business (2019-2024)
Figure 62. Zhejiang Huahai Revenue Growth Rate in Pharmaceutical CMO Services Business (2019-2024)
Figure 63. Jubilant Revenue Growth Rate in Pharmaceutical CMO Services Business (2019-2024)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock